When a North Carolina patient opens their mailbox to find a simple screening test, they're holding the key to catching colorectal cancer before it becomes deadly—and now, new research shows just how powerful that small gesture can be. Dr. Anisha P. Ganguly and her team at UNC Health have documented something remarkable: mailing fecal immunochemical tests (FIT) directly to patients increased colorectal cancer screening by 18.3 percentage points across diverse racial and ethnic groups, a finding that challenges the notion that hard-to-reach populations will simply skip preventive care if barriers aren't removed.
The reason this matters cuts to the heart of health inequity. Colorectal cancer is highly preventable when caught early, yet screening rates remain stubbornly low among underserved communities—partly because patients must navigate appointments, transportation, and the cognitive burden of remembering to schedule care. By removing those friction points and bringing the test home, the intervention created an elegant solution that actually works across lines of race and ethnicity, a rarity in public health interventions.
The trial was straightforward in design but ambitious in scope. Researchers mailed FIT tests to 3,734 patients across two federally qualified health center systems in North Carolina—people who were due for screening but hadn't yet been reached by traditional outreach. The results were consistent and striking: screening rates climbed by 18.3 percentage points overall. Crucially, the bump was similar among Hispanic, non-Hispanic Black, and non-Hispanic white patients, suggesting the intervention genuinely speaks to diverse populations rather than benefiting some groups while leaving others behind.
When patients tested positive and required follow-up colonoscopy, the research team provided patient navigation—trained staff who help guide people through the next steps. This support proved equally effective across racial groups in terms of the intervention's relative impact. Yet the data contained an important sobering note: even as follow-up colonoscopy increased at similar rates, Black patients overall remained less likely to complete colonoscopy than white patients, pointing to barriers that exist beyond the initial screening test itself.
For Dr. Ganguly, an expert in streamlining cancer screening for vulnerable populations at the UNC School of Medicine, the findings underscore both progress and unfinished work. "This analysis showed that mailed colorectal cancer screening tests have the power to improve screening rates for diverse populations," she noted. The team's observation that additional targeted interventions may be needed for Black patients signals their commitment to moving beyond one-size-fits-all solutions toward strategies that account for the specific obstacles different communities face.
The research, published in the Annals of Family Medicine, arrives at a moment when colorectal cancer screening innovations are gaining traction across health systems. What makes this study distinctive is its explicit focus on equity—not just whether the intervention works, but whether it works fairly across populations historically left behind by medical innovation. The next phase of work likely involves understanding what happens after the positive test, ensuring that patient navigation support and follow-up care are designed with the same equity lens that brought the initial test home.